Pharmacokinetic Monitoring of <scp>JAK</scp> Inhibitor and Tacrolimus for Safe and Effective Management of Graft‐Versus‐Host Disease After Pediatric Liver Transplantation
This case illustrates the safe and effective PK-validated use of ruxolitinib with tacrolimus and posaconazole to successfully induce remission of post-LT GVHD in a pediatric patient.
Authors
- Tomoyuki Mizuno (ORCID: https://orcid.org/0000-0002-8471-9826)
- Stella M. Davies (ORCID: https://orcid.org/0000-0002-3137-6647)
- Katsunori Sawada (ORCID: https://orcid.org/0000-0001-9279-4589)
- Akihiro Asai (ORCID: https://orcid.org/0000-0003-3029-5754)
- Pooja Khandelwal (ORCID: https://orcid.org/0000-0002-8627-6408)
- Anna Crooker
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1111/petr.70187
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00